Showing results (301-310 of 753) with videos related to
Sort By:
Pageof 76
Neurology|January 6, 2021
Seizures Among Patients With Brain Metastases: A Population- and Institutional-Level AnalysisNayan Lamba, Paul J Catalano, Daniel N Cagney, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|February 4, 2018
Variable response of CNS hemangioblastomas to Pazopanib in a single patient with von Hippel-Lindau disease: Case reportDavis G Taylor, Adeel Ilyas, Gautam U Mehta, et al.Journal of Neuro-Oncology|May 9, 2014
Histogram analysis of apparent diffusion coefficient within enhancing and nonenhancing tumor volumes in recurrent glioblastoma patients treated with bevacizumabRifaquat Rahman, Alhafidz Hamdan, Rebecca Zweifler, et al.Neuro-Oncology Advances|August 15, 2020
Highlights of the 2019 Society for Neuro-Oncology Inaugural Brain Metastases Conference: establishing a dedicated meeting to address an unmet need in the fieldJeffrey A Zuccato, Ayal A Aizer, Eudocia Quant Lee, et al.Journal of the National Cancer Institute|March 30, 2026
Survival and treatment among older patients with brain metastases: a Population-Based studyBenjamin Grobman, Nayan Lamba, Paul J Catalano, et al.Scientific Reports|January 28, 2021
Phase 2 trial of hypoxia activated evofosfamide (TH302) for treatment of recurrent bevacizumab-refractory glioblastomaAndrew J Brenner, John Floyd, Lisa Fichtel, et al.Cancer|July 4, 2013
Recurrent glioblastoma: volumetric assessment and stratification of patient survival with early posttreatment magnetic resonance imaging in patients treated with bevacizumabRaymond Y Huang, Rifaquat Rahman, Alhafidz Hamdan, et al.Molecular Cancer Therapeutics|December 23, 2011
Cooperation between c-Met and focal adhesion kinase family members in medulloblastoma and implications for therapyFadila Guessous, Yanzhi Yang, Elizabeth Johnson, et al.Cancer Research|January 16, 2014
microRNA-148a is a prognostic oncomiR that targets MIG6 and BIM to regulate EGFR and apoptosis in glioblastomaJungeun Kim, Ying Zhang, Michael Skalski, et al.Journal of Neuro-Oncology|March 20, 2012
Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center studyWhitney B Pope, Xin Joe Qiao, Hyun J Kim, et al.Pageof 76